UNABLES Puzzle Game Set to Debut on Nintendo Switch, PlayStation 4, and Xbox
Exciting news for gaming enthusiasts! UNABLES, the popular puzzle game, is set to debut on Nintendo Switch, PlayStation 4, Xbox One, Xbox Series X, and Xbox Series S on March 14th, 2024. Priced at $12.99/€12.99, the game promises a thrilling experience filled with funny scenarios and physics-based mechanics. Nintendo Switch, Xbox, and PS Plus subscribers can enjoy a 10% release discount, while owners of selected Forever Entertainment games on Nintendo Switch will receive a 50% owner discount. A demo version will be available for the Nintendo Switch version from March 7th, featuring the first three levels and a special control option with a built-in gyroscope. UNABLES is a captivating blend of physics, puzzles, and comedy, offering 15 unique maps and diverse settings for an immersive experience with different mechanics and hidden easter eggs to discover.
ISM to Release February US Manufacturing PMI Report
The Institute for Supply Management (ISM) is set to release the highly anticipated February United States (US) Manufacturing Purchasing Managers’ Index (PMI), a reliable indicator of the US manufacturing sector’s health and the overall economy. Market players will pay close attention to the figures, which are expected to improve, as well as the ISM Prices Paid Index and the Employment Index. The upcoming release is expected to provide valuable insights into the state of the US manufacturing sector and potential market impacts.
LEGO Animal Crossing Sets Are Now Available
LEGO Animal Crossing sets are now available, with five different sets to choose from. The sets range in price and size, with the Nook’s Cranny & Rosie’s House set being the most expensive at £64.99. Will you be picking up any of these sets?
New Research Project to Examine Connections Between Autism and Sensory Hypersensitivity
The Auerbach Lab at the Beckman Institute for Advanced Science and Technology has announced a new research project to examine the connections between autism and sensory hypersensitivity. Lead investigator Benjamin Auerbach emphasized the need to understand the pathways from genes to symptoms, particularly in the auditory system where sensory hypersensitivities are prevalent in individuals with ASD. The research holds promise for uncovering underlying mechanisms that link genetics, neural circuits, and sensory hypersensitivity in individuals with autism spectrum disorders.
Amazon Prime Gaming Offers Free Games in March
Amazon Prime members can enjoy a lineup of free games this March through the Prime Gaming hub, including Fallout 2, Invincible Presents: Atom Eve, Scarf, Mystery Case Files: Moths to a Flame, and Bus Simulator 21. Prime Gaming also offers cloud streaming through Amazon Luna’s Prime Gaming Channel, adding even more games to their library.
Promising Results Unveiled from Immunic’s Phase 2 Clinical Trials for Multiple Sclerosis Therapy
Immunic, Inc. (NASDAQ:IMUX) unveils promising results from phase 2 clinical trials at the ACTRIMS Forum 2024, showing potential for vidofludimus calcium as a therapy for progressive multiple sclerosis and its impact on fatigue possibly linked to Epstein-Barr virus reactivation. The interim analysis revealed a substantial reduction in serum neurofilament light chain levels in PMS patients treated with vidofludimus calcium, indicating potential neuroprotective benefits. The drug also showed promise in preventing EBV reactivation and alleviating fatigue in MS patients. These groundbreaking results mark a significant stride in Immunic’s clinical pipeline.
HDMI Forum Blocks Open Source Implementation, Impacting Linux Users
The HDMI Forum has reportedly told AMD that it does not allow an open source implementation of the HDMI 2.1 specification, effectively blocking tools such as AMD’s FreeSync from working over HDMI connections at high resolutions and frame rates on Linux systems. This decision has significant implications for Linux users, as they are unable to achieve the same resolutions and speeds as Windows users or those using DisplayPort connections. The rejection of an open source HDMI 2.1 implementation has raised concerns and speculation, with some suggesting potential interference from media firms worried about digital video ripping. This decision has significant implications for the Linux community and highlights the ongoing challenges faced by open source developers in accessing and implementing industry standards.
New Study Offers Hope for Cartilage Regeneration in Arthritic Mice
New study offers hope for potential alternative treatment for osteoarthritis. Researchers identify new type of stem cell with potential for knee cartilage regeneration in arthritic mice. Findings pave way for potential development of cartilage replacement therapy for OA patients.
TikTok users report spread of ‘mystery virus’
TikTok users have been reporting the spread of a ‘mystery virus’ causing concern among young people. Despite testing negative for COVID-19, RSV, and the flu, users are experiencing symptoms such as nausea, excess mucus, and feeling faint. The reports have sparked discussions and speculations on social media, particularly on TikTok, where users have been sharing their experiences and seeking answers. Health experts have been urging caution and advising individuals to seek medical attention if they experience any concerning symptoms. The emergence of this ‘mystery virus’ has raised awareness about the importance of staying informed and taking appropriate health precautions.
2024 Clinical Practice Guideline on Salvage Therapy for Prostate Cancer Released by AUA, ASTRO, and SUO
The 2024 clinical practice guideline on salvage therapy for prostate cancer has been released by the American Urological Association (AUA), in partnership with the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO). The guideline emphasizes the importance of balancing undertreatment with overtreatment, utilizing new therapeutic agents and imaging modalities, and optimizing patient selection with evidence-driven prognostic markers to improve oncologic outcomes and maintain the quality of life for these patients.